Search result for 'piramal pharma'

Piramal Critical Care and BrePco Biopharma have secured UK approval for Neoatricon, a medication for low blood pressure and heart rate in children, addressing a critical gap in paediatric care.

India's DGTR recommends anti-dumping duty on Vitamin A Palmitate imports from China, EU, and Switzerland due to dumping impacting domestic industry.

Standard Glass Lining Technology Ltd's IPO was oversubscribed by 182.57 times, with strong demand from QIBs, non-institutional investors, and retail investors. The IPO raised Rs 410.05 crore.

Standard Glass Lining Technology's IPO received 34.82 times subscription on day 2, with strong demand from non-institutional investors and retail investors. The IPO was fully subscribed on the...

Standard Glass Lining Technology's IPO was fully subscribed within minutes of opening, receiving 3.22 times subscription. The issue, with a price band of Rs 133-140 per share, will conclude on...

Standard Glass Lining Technology has raised Rs 123 crore from anchor investors ahead of its IPO, which opens on January 6. The IPO comprises a fresh issue and an offer for sale (OFS).

Standard Glass Lining Technology's IPO opens on January 6 with a price band of Rs 133-140 per share, aiming to raise Rs 410.05 crore. The IPO includes a fresh issue and an offer for sale by...

Piramal Pharma has agreed to pay USD 407,400 to VetDC, Inc to settle a dispute over rejected batches of a product. The company says the settlement will not significantly impact its financial position.

Piramal Pharma, aiming for USD 2 billion revenue by FY30, will invest USD 85 million in capex this fiscal for capacity expansion, maintenance, and de-bottlenecking of CDMO sites.

Piramal Pharma aims to become a USD 2 billion global pharma, health and wellness firm by FY30. The company is targeting growth in its CDMO, critical care, and consumer healthcare verticals.

Standard Glass Lining Technology, a leading manufacturer of pharma and chemical equipment, files for an IPO seeking ₹500 crore. The IPO includes fresh issuance and an OFS, with proceeds for debt...

Piramal Pharma swings back to profitability with a Rs 10 crore net profit in Q3, driven by growth in contract development and manufacturing business.

Piramal Pharma Solutions Inc, a subsidiary of Piramal Pharma, is facing a civil suit from VetDC Inc seeking $8.91 million in damages for alleged breaches in a supply agreement. The lawsuit concerns...

India's pharmaceutical sector is projected to reach USD 130 billion by 2030, driven by expanding market opportunities and rising global demand. Experts highlight the industry's growth trajectory...